Leberzirrhose und Komplikationen

  • U. Leuschner
  • T. Lenz
  • B. Lembcke
  • H. Seifert
  • I. Scharrer
  • G. Kircheis
  • W. F. Caspary

Zusammenfassung

Die Leberzirrhose ist eine chronische Leberkrankheit, die langsam entsteht und allmählich durch ständig zugrundegehendes Lebergewebe und dieses ersetzendes Bindegewebe zu irreversiblen Veränderungen führt. Auslöser des allmählichen Leberumbaus sind chronische Leberkrankheiten oder chronisch auf die Leber einwirkende Noxen. Betroffen ist immer das gesamte Organ. Die Krankheit kann asymptomatisch verlaufen oder mit wenigen uncharakteristischen oder auch starken Beschwerden einhergehen, die dann häufig auf lebensbedrohliche Komplikationen hinweisen. Die wichtigsten Komplikationen der Leberzirrhose sind der Aszites, die Ösophagusvarizenblutung und die hepatische Enzephalopathie.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Gerok W (1984) Leberzirrhose. In: Demling L (Hrsg) Klinische Gastroenterologie. Thieme, Stuttgart, New York, Bd II, S 115–151Google Scholar
  2. Gerok W (1981) Therapie der Protein– und Aminosäurenstoffwechselstörungen bei Leberkrankheiten. Leber-Magen-Darm 11: 63–72PubMedGoogle Scholar
  3. Köllinger M, Kullmann F, Holstege A, Schölmerich J (1996) Prophylaxe und Therapie von Komplikationen der Leberzirrhose: Aszites, Enzephalopathie und Malnutrition. Med Klin 91: 89–102Google Scholar
  4. Melato M, Mucli E (1989) Something new in liver cirrhosis epidemiology. Lancet 2: 395–396PubMedCrossRefGoogle Scholar
  5. Müller MJ, Lantz HU, Selberg O, Canzler H, Schmidt FW (1991) Ernährung bei chronischen Leberkrankheiten. Dtsch Med Wochenschr 116: 909–916PubMedCrossRefGoogle Scholar
  6. Epstein FH, Post RS, McDowell M (1953) The effect of an arteriovenous fistula on renal he-modynamics and electrolyte excretion. J Clin Invest 32: 233–241PubMedCrossRefGoogle Scholar
  7. Epstein M (1991) Renal disorders in liver disease. In: Suki WN, Massry SG (Hrsg.) Therapy of renal diseases and related disorders, 2nd edn. Kluwer, Dordrecht, S 477–493CrossRefGoogle Scholar
  8. Epstein M (1989) Treatment of refractory ascites. N Engl J Med 321: 220–228Google Scholar
  9. Nicholls KM, Shapiro MD, Groves BS, Schrier RW (1986) Factors determining renal response to water immersion in non-excretor cirrhotic patients. Kidney Int 30: 417–421PubMedCrossRefGoogle Scholar
  10. Philipp T, Köhler H (1994) Gastrointestinale Systeme (einschließlich Leber). In: Brass H, Philipp T, Schulz W (Hrsg) Manuale Nephrologicum Dustri, Deisenhofen, VII 4/7, S 1–11Google Scholar
  11. Schrier RW, Caramelo C (1987) Hemodynamics and hormonal alterations in hepatic cirrhosis. In: Epstein M (Hrsg) The kidney in liver disease. Williams & Wilkins, New YorkGoogle Scholar
  12. Schrier RW (1988) Pathogenesis of sodium and water retention in high-output and low-out- put cardiac failure, nephrotic syndrome, cirrhosis and pregnancy. N Engl J Med 319: 1127–1134PubMedCrossRefGoogle Scholar
  13. Epstein M (1982) Peritoneovenous shunt in the management of ascites and the hepatorenalGoogle Scholar
  14. syndrome. Gastroenterology 82:790–794Google Scholar
  15. Epstein M (1989) Treatment of refractory ascites. N Engl J Med 321: 1675–1677PubMedCrossRefGoogle Scholar
  16. Gerbes AL, Paumgartner G (1994) Diagnostik des Aszites. Dtsch Med Wochenschr 119: 1507–1511PubMedCrossRefGoogle Scholar
  17. Gerbes AL, Paumgartner G (1994) Therapie des Aszites bei Lebererkrankungen. Dtsch Med Wochenschr 119: 1549–1554PubMedCrossRefGoogle Scholar
  18. Ginés P, Titó L, Arroyo Vet al. (1988) Randomized comparative study of therapeutic paracentesis with and without albumin in cirrhosis. Gastroenterology 94: 1493–1502PubMedGoogle Scholar
  19. Pinzani M, Daskalopoulos G, Laffi G, Gentilini P, Zipser RD (1987) Altered furosemide pharmacokinetics in chronic alcoholic liver disease with ascites contributes to diuretic resistance. Gastroenterology 92: 294–298PubMedGoogle Scholar
  20. Schölmerich J, Zimmermann U, Röttgen E et al. (1988) Proteases and antiproteases related to the coagulation system in plasma and ascites. Prediction of coagulation disorders in ascites retransfusion. J Hepatol 6: 359–363Google Scholar
  21. Schölmerich J (1991) Aszites. Pathophysiologic - Diagnostik - Therapie. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  22. Arroyo V, Navasa M, Rimola A (1994) Spontaneous bacterial peritonitis in liver cirrhosis:Google Scholar
  23. Treatment and prophylaxis. Infection 22 (Suppl. 3):167–175Google Scholar
  24. Cabre E, Gonzalez-Huix F, Abad-Lacruz A et al. (1990) Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics. Gastroenterology 98: 715–720PubMedGoogle Scholar
  25. Gilbert JA, Kamath PS (1995) Spontaneous bacterial peritonitis: An update. Mayo Clin Proc 70: 365–370Google Scholar
  26. Press AG, Meyer zum Büschenfelde KH, Ramadori G (1992) Die spontane bakterielle Perito¬nitis. Z Gastroenterol 30: 543–552PubMedGoogle Scholar
  27. Rimola A, Navasa M, Arroyo V (1995) Experience with cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis. Diagn Microbiol Infect Dis 22: 141–145PubMedCrossRefGoogle Scholar
  28. Rolando N, Harvey F, Brahm J et al. (1990) Prospective study of bacterial infection in acute liver failure: An analysis of fifty cases. Hepatology 11: 49–53Google Scholar
  29. Runyon BA, van Epps DE (1986) Diuresis of cirrhotic ascites increases its opsonic activity and may help prevent spontaneous bacterial peritonitis. Hepatology 6: 396–399PubMedCrossRefGoogle Scholar
  30. Schölmerich J, Gerbes AL, Andus T, Leser H-G (1995) Spontane bakterielle Peritonitis bei Leberzirrhose mit Aszites. Dtsch Med Wochenschr 120: 454–461PubMedCrossRefGoogle Scholar
  31. Soriano G, Guarner C, Teixido M et al. (1991) Selective intestinal decontamination prevents spontaneous bacterial peritonitis. Gastroenterology 100: 477–481PubMedGoogle Scholar
  32. Tito L, Rimola A, Gines P et al. (1988) Recurrence of spontaneous bacterial peritonitis in cirrhosis: Frequency and predictive factors. Hepatology 8: 27–31Google Scholar
  33. Angelico M, Carli L, Piat C et al. (1993) Isosorbide-5-mononitrate versus propranolol in the prevention of first bleeding in cirrhosis. Gastroenterology 104: 1460–1465PubMedGoogle Scholar
  34. Besson I, Ingrand P, Person B et al. (1995) Sclerotherapy with or without octreotide for acute variceal bleeding. N Engl J Med 333: 555–560PubMedCrossRefGoogle Scholar
  35. Brocchi E, Caletti G, Brambilla G et al. (1988) Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med 319: 983–989Google Scholar
  36. Conn HO, Rambsby GR, Storer EH et al. (1975) Intraarterial vasopressin in the treatment of upper gastrointestinal hemorrhage: a prospective controlled clinical trial. Gastroenterology 68: 211–221PubMedGoogle Scholar
  37. D’Amico G, Pagliaro L, Bosch J (1995) The treatment of portal hypertension: A meta-analytic review. Hepatology 22: 332–354Google Scholar
  38. Feretis C, Dimopoulos C, Benakis P, Kalliakmanis B, Apostolidis N (1995) N-butyl-2-cya- noacrylate (Histoacryl) plus sclerotherapy versus sclerotherapy alone in the treatment of bleeding esophageal varices: a randomized prospective study. Endoscopy 27: 355–357PubMedCrossRefGoogle Scholar
  39. Ganguly S, Sarin SK, Bhatia V, Lahoti D (1995) The prevalence and spectrum of colonic lesions in patients with cirrhotic and noncirrhotic portal hypertension. Hepatology 21: 1226–1231PubMedGoogle Scholar
  40. Grace ND (1992) Prevention of initial variceal hemorrhage. Gastroenterol Clin North Am 21: 149–161PubMedGoogle Scholar
  41. Hashizume M, Kitano S, Koyanagi N (1992) Endoscopic injection sclerotherapy for 1000 patients with esophageal varices: A nine-year prospective study. Hepatology 15:69– 75Google Scholar
  42. Jutabha R, Jensen DM, See J, Machicado G, Hirabayashi K (1995) Randomized, controlled study of various agents for endoscopic injection sclerotherapy of bleeding canine gastric varices. Gastrointest Endosc 41: 206–211PubMedCrossRefGoogle Scholar
  43. Kitano S, Terblanche J, Kahn D, Bornman PC (1986) Venous anatomy of the lower oesophagus in portal hypertension: Practical implication. Br J Surg 73: 525–531Google Scholar
  44. Kleber G, Sauerbruch T, Ansari H, Paumgartner G (1991) Prediction of variceal hemorrhage in cirrhosis: A prospective follow-up study. Gastroenterology 100: 1332–1337Google Scholar
  45. Lebrec D, Poynard T, Hillon P, Benhamou J (1981) Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis. N Engl J Med 305: 1371–1374PubMedCrossRefGoogle Scholar
  46. Orlof MJ, Orloff MS, Orlff SL, Haynes KS (1995) Treatment of bleeding from portal hypertensive gastropathy by portocaval shunt. Hepatology 21: 1011–1017Google Scholar
  47. Rigo GP, Merighi A, Chahin NJ et al. (1992) A prospective study of the ability of three endoscopic classifications to predict hemorrhage from esophageal varices. Gastrointest Endosc 38: 425–429PubMedCrossRefGoogle Scholar
  48. Soehendra N, Nam VC, Grimm H, Kempeneers I (1986) Endoscopic obliteration of large esophageal varcies with bycrylate. Endoscopy 18: 25–26PubMedCrossRefGoogle Scholar
  49. Stiegmann GV, Goff JS, Michaletz-Onody PA (1992) Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med 326:1527– 1532Google Scholar
  50. Thakeb F, Salama Z, Raouf TA, Kader SA, Hamid HA (1995) The value of combines use of N-butyl-2-cyanoacrylate and ethanolamine oleate in the management of bleeding oeso- phagogastric varices. Endoscopy 27: 358–364PubMedCrossRefGoogle Scholar
  51. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices (1988): Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A protective multicenter study. N Engl J Med 319: 983–989CrossRefGoogle Scholar
  52. Vianna A, Hayes PC, Moscoso G, Driver M, Portmann B, Westaby D, Williams R (1987) Normal venous circulation of the gastroesophageal junction: A route to understanding varices. Gastroenterology 93: 876–889Google Scholar
  53. Bizollon T (1991) Fibrinolytic therapy for portal vein thrombosis. Lancet 337: 1416PubMedCrossRefGoogle Scholar
  54. Carmassi F, Morale M, De Negri F, Carrai M (1995) Modulation of hemostatic balance with antithrombin III replacement therapy in a case of liver cirrhosis associated with recurrent venous thrombosis. J Mol Med 73: 89–93PubMedCrossRefGoogle Scholar
  55. DeCaterina MI, Tarantino G, Farina C (1993) Haemostasis unbalance in Pugh-scored liver cirrhosis; Characteristic changes of plasma levels of protein C versus Protein S. Haemostasis 23: 229Google Scholar
  56. Mammen EF (1994) Coagulopathies of liver disease. Clin Lab Med 14: 769–780PubMedGoogle Scholar
  57. Mann O, Haag K, Hauenstein KH, Rössle M, Pausch J (1995) Septische Pfortaderthrombose. Dtsch Med Wochenschr 120: 1201–1206PubMedCrossRefGoogle Scholar
  58. Mannucci PM, Vicente V, Vianello L (1986) Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time. Blood 67: 1148PubMedGoogle Scholar
  59. Scharrer I, Encke A, Hottenrott C (1988) Clinical cure of haemophilia A by liver transplantation. Lancet 1: 800–801CrossRefGoogle Scholar
  60. Scharrer I (1995) The need for highly purified products to treat hemophilia B. Acta Haematologica 94 (Suppl. l): 2–7PubMedCrossRefGoogle Scholar
  61. Violi F, Ferro D, Basili S, Artini M, Valesini G, Levrero M, Cordova C (1995) Increased rate of thrombin generation in hepatitis C virus cirrhotic patients. Relationships to venous thrombosis. J Invest Med 43: 550–554Google Scholar
  62. Violi F, Ferro D, Basili S, Cimminiello C, Saliola M,Vezza E,Cordova C, and the CALC Group(1995) Prognostic value of clothing and fibrinolytic systems in a follow-up of 165 liver cirrhotic patients. Hepatology 22: 96–100Google Scholar
  63. Basile AS, Hughes RD, Harrison PM, Murata Y, Pannell L, Jones EA et al. (1991) Elevated brain concentrations of 1,4-benzodiazepine in fulminant hepatic failure. N Engl J Med 325: 473–478PubMedCrossRefGoogle Scholar
  64. Butterworth RF (1995) Hepatic encephalopathy. Neurologist 1: 95–104Google Scholar
  65. Candranel JF, El Younsi M, Pidoux B, Zylberberg P, Benhamou Y, Valla D et al. (1995) Flumazenil therapy for hepatic encephalopathy in cirrhotic patients: a double-blind pragmatic randomized, placebo study. Europ J Gastroenterol Hepatol 7: 325–329Google Scholar
  66. Charlton MR (1996) Branched chains revisited. Gastroenterology 111: 252–255PubMedCrossRefGoogle Scholar
  67. Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seef L, Levy LL (1977) Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy: a double blind controlled trial. Gastroenterology 72: 573–583PubMedGoogle Scholar
  68. Ferenci P, Püspök A, Steindl P (1992) Current concepts in the pathophysiology of hepaticGoogle Scholar
  69. encephalopathy. Eur J Clin Invest 22:573–581Google Scholar
  70. Gyr K, Meier R, Häussler J, Bouletreau P, Fleig WE, Gatta A et al (1996) Evaluation of the efficacy and safety of flumazenil in the treatment of portal systemic encephalopathy: a double blind, randomized, placebo controlled multicentre study. Gut 39: 319–324.PubMedCrossRefGoogle Scholar
  71. Häussinger D, Maier KP (Hrsg) (1996) Hepatische Enzephalopathie. Thieme, StuttgartGoogle Scholar
  72. Häussinger D, Laubenberger J, vom Dahl S, Ernst T, Bayer S, Langer M et al. (1994) Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy. Gastroenterology 107: 1475–1480PubMedGoogle Scholar
  73. Holstege A, Lock G, Köllinger M, Schölmerich J (1996) Conservative treatment of acute hepatic failure. Z Gastroenterologie 34: 192–201Google Scholar
  74. Kircheis G, Quack G, Erbler H (1994) L-ornithine-L-aspartate (OA) in the treatment of hyperammoniemia and hepatic encephalopathy - experimental aspects and clinical trials. In: Conn HO, Bircher J (Hrsg) Hepatic encephalopathy: Syndromes and therapies. Medi- Ed Press, Bloomington, S 373–383Google Scholar
  75. Kircheis G, Nilius R, Held C, Berndt H, Buchner M, Görtelmeyer R et al (1997) Hepatology 25: 1351–1360PubMedCrossRefGoogle Scholar
  76. Koch H, Schauder P, Schäfer G, Dahme B, Ebel W, Vahldiek B et al. (1990) Untersuchungen zur Diagnose und Prävalenz der latenten hepatischen Encephalopathie. Z Gastroenterolo¬gie 28: 610–615Google Scholar
  77. Köllinger M, Kullmann F, Holstege A, Schölmerich J (1996) Prophylaxe und Therapie von Komplikationen der Leberzirrhose: Aszites, Enzephalopathie und Malnutrition. Med Klin 91: 89–102Google Scholar
  78. Lee WM (1993) Acute liver failure. N Engl J Med 329: 1862–1872PubMedCrossRefGoogle Scholar
  79. Lee WM (1995) Drug-induced hepatotoxicity. N Engl J Med 333: 1118–1127PubMedCrossRefGoogle Scholar
  80. Naylor CD, O’Rorke K, Detsky AS, Baker JP (1989) Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy. A meta-analysis. Gastroenterology 97: 1033–1042Google Scholar
  81. Pomier-Layrargues G, Giguere JF, Lavoie J, Perney P, Gagnon S, Damour M, Wells J, Butterworth RF (1994) Flumazenil in cirrhotic patients in hepatic coma: a randomized double- blind placebo-controlled crossover trial. Hepatology 19: 32–37PubMedGoogle Scholar
  82. Record CO (1991) Neurochemistry of hepatic encephalopathy. Gut 32: 1261–1263PubMedCrossRefGoogle Scholar
  83. Riggio O, Balducci G, Ariosta F, Merli M, Temitera S, Ziparo V, Capocaccia L (1990) Lactitol in the treatment of chronic hepatic encephalopathy: a randomized cross-over comparison with lactulose. Hepatogastroenterol 37: 524–527Google Scholar
  84. Riggio O, Ariosto F, Merli M, Caschera M, Zullo A, Balducci G, Ziparo V, Pedrett G, Fiacca- dori F, Bottari E, Capocaccia L (1991) Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double-blind cross-over trial. Dig Dis Sci 36: 1204–1208Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • U. Leuschner
  • T. Lenz
  • B. Lembcke
  • H. Seifert
  • I. Scharrer
  • G. Kircheis
  • W. F. Caspary

There are no affiliations available

Personalised recommendations